Chao‐Pin Lee

633 total citations
16 papers, 368 citations indexed

About

Chao‐Pin Lee is a scholar working on Oncology, Biochemistry and Molecular Biology. According to data from OpenAlex, Chao‐Pin Lee has authored 16 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Biochemistry and 4 papers in Molecular Biology. Recurrent topics in Chao‐Pin Lee's work include Drug Transport and Resistance Mechanisms (10 papers), Amino Acid Enzymes and Metabolism (6 papers) and HIV/AIDS drug development and treatment (3 papers). Chao‐Pin Lee is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), Amino Acid Enzymes and Metabolism (6 papers) and HIV/AIDS drug development and treatment (3 papers). Chao‐Pin Lee collaborates with scholars based in United States, United Kingdom and Czechia. Chao‐Pin Lee's co-authors include Philip L. Smith, Remco L.A. de Vrueh, Kiyoshi Tamura, Pradip K. Bhatnagar, Ronald T. Borchardt, Ismael J. Hidalgo, Weiqing Chen, Glynn Wilson, Mikael Begtrup and Ronald T. Borchardt and has published in prestigious journals such as Advanced Drug Delivery Reviews, Biochemical and Biophysical Research Communications and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Chao‐Pin Lee

16 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chao‐Pin Lee United States 12 179 131 85 63 61 16 368
Heiner Glombik Germany 15 312 1.7× 344 2.6× 32 0.4× 45 0.7× 38 0.6× 24 713
Ian D. Collier United Kingdom 12 235 1.3× 192 1.5× 19 0.2× 44 0.7× 122 2.0× 19 448
Todd M. Baughman United States 11 401 2.2× 221 1.7× 45 0.5× 85 1.3× 15 0.2× 12 606
Eric Y. Zhang United States 9 187 1.0× 127 1.0× 48 0.6× 17 0.3× 33 0.5× 11 425
Catherine S. Temple United Kingdom 7 244 1.4× 150 1.1× 13 0.2× 44 0.7× 133 2.2× 10 350
Narayanan Surendran United States 12 107 0.6× 146 1.1× 62 0.7× 29 0.5× 17 0.3× 22 462
Yolanda Romsicki Canada 10 487 2.7× 400 3.1× 25 0.3× 64 1.0× 28 0.5× 11 697
Sarah Goldenberg United States 11 447 2.5× 285 2.2× 21 0.2× 83 1.3× 27 0.4× 13 598
Stephan Kopp Austria 13 438 2.4× 252 1.9× 33 0.4× 114 1.8× 16 0.3× 24 698
Er-jia Wang China 8 255 1.4× 159 1.2× 19 0.2× 63 1.0× 13 0.2× 9 468

Countries citing papers authored by Chao‐Pin Lee

Since Specialization
Citations

This map shows the geographic impact of Chao‐Pin Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao‐Pin Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao‐Pin Lee more than expected).

Fields of papers citing papers by Chao‐Pin Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chao‐Pin Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao‐Pin Lee. The network helps show where Chao‐Pin Lee may publish in the future.

Co-authorship network of co-authors of Chao‐Pin Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Chao‐Pin Lee. A scholar is included among the top collaborators of Chao‐Pin Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chao‐Pin Lee. Chao‐Pin Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Chen, Weiqing, et al.. (2002). Synthesis of analogs of l-valacyclovir and determination of their substrate activity for the oligopeptide transporter in Caco-2 cells. European Journal of Pharmaceutical Sciences. 16(1-2). 1–13. 47 indexed citations
2.
Li, Jibin, Kiyoshi Tamura, Chao‐Pin Lee, et al.. (1998). Structure-Affinity Relationships of Val-Val and Val-Val-val Stereoisomers with the Apical Oligopeptide Transporter in Human Intestinal Caco-2 Cells. Journal of drug targeting. 5(5). 317–327. 14 indexed citations
3.
Vrueh, Remco L.A. de, Philip L. Smith, & Chao‐Pin Lee. (1998). Transport of l-Valine-Acyclovir Via the Oligopeptide Transporter In The Human Intestinal Cell Line, Caco-2. Journal of Pharmacology and Experimental Therapeutics. 286(3). 1166–1170. 69 indexed citations
4.
Samanen, James M., Chao‐Pin Lee, Philip L. Smith, et al.. (1997). The use of rabbit intestinal permeability as an in vitro assay in the search for orally active GPIIb/IIIa antagonists. Advanced Drug Delivery Reviews. 23(1-3). 133–142. 1 indexed citations
5.
Ellens, Harma, Chao‐Pin Lee, Amparo M. Lago, et al.. (1997). In vitro permeability screening for identification of orally bioavailable endothelin receptor antagonists. Advanced Drug Delivery Reviews. 23(1-3). 99–109. 13 indexed citations
6.
Lee, Chao‐Pin, Remco L.A. de Vrueh, & Philip L. Smith. (1997). Selection of development candidates based on in vitro permeability measurements. Advanced Drug Delivery Reviews. 23(1-3). 47–62. 37 indexed citations
7.
Tamura, Kiyoshi, et al.. (1996). Effect of Charge on Oligopeptide Transporter-Mediated Permeation of Cyclic Dipeptides Across Caco-2 Cell Monolayers. Pharmaceutical Research. 13(11). 1752–1754. 16 indexed citations
8.
Keller, Paul M., et al.. (1996). Endothelin-Converting Enzyme: Substrate Specificity and Inhibition by Novel Analogs of Phosphoramidon. Biochemical and Biophysical Research Communications. 223(2). 372–378. 16 indexed citations
9.
Tamura, Kiyoshi, Chao‐Pin Lee, Philip L. Smith, & Ronald T. Borchardt. (1996). Metabolism, Uptake, and Transepithelial Transport of the Stereoisomers of Val-Val-Val in the Human Intestinal Cell Line, Caco-2. Pharmaceutical Research. 13(11). 1663–1667. 13 indexed citations
10.
Tamura, Kiyoshi, et al.. (1996). Metabolism, uptake, and transepithelial transport of the diastereomers of Val-Val in the human intestinal cell line, Caco-2.. Pharmaceutical Research. 13(8). 1213–1218. 36 indexed citations
11.
Smith, Philip L., et al.. (1996). Exploitation of the intestinal oligopeptide transporter to enhance drug absorption. Drug Delivery. 3(2). 117–123. 3 indexed citations
12.
Samanen, James M., Glynn Wilson, Philip L. Smith, et al.. (1996). Chemical Approaches to Improve the Oral Bioavailability of Peptidergic Molecules. Journal of Pharmacy and Pharmacology. 48(2). 119–135. 22 indexed citations
13.
Hidalgo, Ismael J., et al.. (1995). Structural Requirements for Interaction with the Oligopeptide Transporter in Caco-2 Cells. Pharmaceutical Research. 12(2). 317–319. 53 indexed citations
14.
Smith, Philip L., et al.. (1993). Exploitation of the Intestinal Oligopeptide Transporter to Enhance Drug Absorption. Drug Delivery. 1(2). 103–111. 18 indexed citations
15.
Mariano, Patrick S., et al.. (1991). Stereochemical Characteristics of Set-promoted Photochemical Reactions of Dihydroisoquinolinium Salts. Heterocycles. 32(11). 2161–2161. 5 indexed citations
16.
Lee, Chao‐Pin, et al.. (1989). Stereochemical aspects of photo-set induced diradical cyclization reactions as part of isoquinoline alkaloid synthetic strategies. Tetrahedron Letters. 30(7). 799–802. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026